APYX vs CAT · rev $48.1M vs P/E 48, rev $20.54B
Apyx Medical Inc (APYX) versus Caterpillar Inc (CAT) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
APYX currently screens at market cap $179.6M. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Not investment advice. Open the APYX and CAT stock pages for the full models.
Not investment advice.